Emerging salivary biomarkers by mass spectrometry

Clinica Chimica Acta

Volumn 438, Issue , 2014, Pages 214-221

  Wang, Qihui ^a,b   Yu, Qiaoling ^a,c   Lin, Qingyu ^a   Duan, Yixiang ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU NORMAL UNIVERSITY   (China)

^c Liuzhou Vocational and Technical College   (China)

Author keywords

Biomarker; Disease diagnosis; Mass spectrometry; Non invasive; Saliva

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BIOLOGICAL MARKER; CA 125 ANTIGEN; CALGRANULIN A; CALGRANULIN B; CATALASE; CD59 ANTIGEN; CD79B ANTIGEN; CYCLIN D1; CYSTATIN S; ENDOTHELIN 1; GELATINASE B; HERMES ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MASPIN; MICRORNA 31; NUCLEAR RECEPTOR COACTIVATOR; PROFILIN; SOMATOMEDIN; THIOREDOXIN; TISSUE POLYPEPTIDE ANTIGEN; TRANSCRIPTION FACTOR 3; TRANSFERRIN; VASCULOTROPIN A;

CLINICAL PROTOCOL; EARLY DIAGNOSIS; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUTH CANCER; PANCREAS CANCER; PERIODONTITIS; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; SALIVA ANALYSIS; SJOEGREN SYNDROME; STOMACH CANCER; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION STUDY; CHEMISTRY; CLASSIFICATION; DISEASES; PROCEDURES; SALIVA;

BIOLOGICAL MARKERS; DISEASE; EARLY DIAGNOSIS; HUMANS; MASS SPECTROMETRY; SALIVA;

EID: 84907164016     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.08.037     Document Type: Review

References (82)

1. Humphrey S.P., Williamson R.T. A review of saliva: normal composition, flow, and function. J Prosthet Dent 2001, 85(2):162-169.
2. Defabianis P., Re F. The role of saliva in maintaining oral health. Minerva Stomatol 2003, 52:301-308.
3. Xiao H., Wong D.T. Proteomics and its applications for biomarker discovery in human saliva. Bioinformation 2011, 5(7):294-296.
4. Lee Y.H., Wong D.T. Saliva: an emerging biofluid for early detection of diseases. Am J Dent 2009, 22(4):241-248.
5. De Almeida P.V., Gregio A.M., Machado M.A., De Lima A.A., Azevedo L.R. Saliva composition and functions: a comprehensive review. J Contemp Dent Pract 2008, 9(3):72-80.
6. Pinka R., Simeka J., Vondrakovab J., Faberb E., Michla P., Pazderaa J., et al. Saliva as a diagnostic medium. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2009, 153(2):103-110.
7. Wong D.T. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc 2006, 137(3):313-321.
8. Pfaffe T., Cooper-White J., Beyerlein P., Kostner K., Punyadeera C. Diagnostic potential of saliva: current state and future applications. Clin Chem 2011, 57(5):675-687.
9. Wang Q., Gao P., Wang X., Duan Y. Investigation and identification of potential biomarkers in human saliva for the early diagnosis of oral squamous cell carcinoma. Clin Chim Acta 2013, 427:79-85.
10. Amado F., Lobo M.J.C., Domingues P., Duarte J.A., Vitorino R. Salivary peptidomics. Expert Rev Proteomics 2010, 7(5):709-721.
11. Edgar W.M. Saliva and dental health. Clinical implications of saliva: report of a consensus meeting. Br Dent J 1990, 169:96-98.
12. Miller C.S., Foley J.D., Bailey A.L., Campell C.L., Humphries R.L., Christodoulides N., et al. Current developments in salivary diagnostics. Biomarkers 2010, 4(1):171-189.
13. Motamayel F.A., Davoodi P., Dalband M., Hendi S.S. Saliva as a mirror of the body health. Dent J Hamamdan Univ Med Sci 2010, 1:1-15.
14. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 1993, 694:72-77.
15. Fleissig Y., Deutsch O., Reichenberg E., Redlich M., Zaks B., Palmon A., et al. Different proteomic protein patterns in saliva of Sjo¨gren's syndrome patients. Oral Dis 2009, 15(1):61-68.
16. Wu Z.Z., Wang J.G., Zhang X.L. Diagnostic model of saliva protein finger print analysis of patients with gastric cancer. World J Gastroenterol 2009, 15(7):865-970.
17. Wu Y., Shu R., Luo L.J., Ge L.H., Xie Y.F. Initial comparison of proteomic profiles of whole unstimulated saliva obtained from generalized aggressive periodontitis patients and healthy control subjects. J Periodontal Res 2009, 44(5):636-644.
18. Ohshiro K., Rosenthal D.I., Koomen J.M., Streckfus C.F., Chambers M., Kobayashi R., et al. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma. Int J Oncol 2007, 30(3):743-749.
19. Denny P., Hagen F.K., Hardt M., Liao L., Yan W., Arellanno M., et al. The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res 2008, 7(5):1994-2006.
20. Hirtz C., Chevalier F., Sommerer N., Raingeard I., Bringer J., Rossignol M., et al. Salivary protein profiling in type I diabetes using two-dimensional electrophoresis and mass spectrometry. Clin Proteomics 2006, 2(1):117-127.
21. Schipper R., Loof A., De Groot J., Harthoorn L., Van Heerde W., Dransfield E. Salivary protein/peptide profiling with SELDI-TOF-MS. Ann N Y Acad Sci 2007, 1098(1):498-503.
22. Fang X., Zhang W.W. Affinity separation and enrichment methods in proteomic analysis. J Proteomics 2008, 71(3):284-303.
23. Deutsch O., Fleissig Y., Zaks B., Krief G., Aframian D.J., Palmon A. An approach to remove alpha amylase for proteomic analysis of low abundance biomarkers in human saliva. Electrophoresis 2008, 29(20):4150-4157.
24. Ehsan S., Ball G., Choke E., Molyneux K., London N., Herbert K., et al. Disease specific biomarkers of abdominal aortic aneurysms detected by Surface Enhanced Laser Desorption Ionization Time of Flight Mass Spectrometry. Eur J Vasc Endovasc 2012, 44(1):52-54.
25. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975, 250(10):4007-4021.
26. Ghafouri B., Tagesson C., Lindahl M. Mapping of proteins in human saliva using two-dimensional gel electrophoresis and peptide mass fingerprinting. Proteomics 2003, 3(6):1003-1015.
27. Hu S., Xie Y., Ramachandran P., Ogorzalek Loo R.R., Li Y., Loo J.A., et al. Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 2005, 5(6):1714-1728.
28. Yamada N., Yuji R., Suzuki E. The current status and future prospects of the salivary proteome. J. Health Sci. 2009, 55(5):682-688.
29. Petersen A. Two-dimensional electrophoresis replica blotting: a valuable technique for the immunological and biochemical characterization of single components of complex extracts. Proteomics 2003, 3(7):1206-1214.
30. Hu S., Arellano M., Boontheung P., Wang J., Zhou H., Jiang J., et al. Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 2008, 14(19):6246-6252.
31. van Wietmarschen H.A., Dai W., van der Kooij A.J., Reijmers T.H., Schroe¨n Y., Wang M., et al. Characterization of rheumatoid arthritis subtypes using symptom profiles, clinical chemistry and metabolomics measurements. PLoS One 2012, 7(9):e44331.
32. Tan Y., Yin P., Tang L., Xing W., Huang Q., Cao D., et al. Metabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosis. Mol Cell Proteomics 2012, 11(2).
33. Ambatipudi K.S., Swatkoski S., Moresco J.J., Tu P.G., Coca A., Anolik J.H., et al. Quantitative proteomics of parotid saliva in primary Sjo¨gren's syndrome. Proteomics 2012, 12:3113-3120.
34. Chen E.I., Yates J.R. Cancer proteomics by quantitative shotgun proteomics. Mol Oncol 2007, 1(2):144-159.
35. Ye M., Jiang X., Feng S., Tian R., Zou H. Advances in chromatographic techniques and methods in shotgun proteome analysis. Trends Anal Chem 2007, 26(1):80-84.
36. Adkins J.N., Varnum S.M., Auberry K.J., Moore R.J., Angell N.H., Smith R.D., et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 2002, 1:947-955.
37. Xiao H., Zhang L., Zhou H., Lee J.M., Garon E.B., Wong D.T.W. Proteomic analysis of human saliva from lung cancer patients using two-dimensional difference gel electrophoresis and mass spectrometry. Mol Cell Proteomics 2012, 11(2).
38. Korostoff A., Reder L., Masood R., Sinha U.K. The role of salivary cytokine biomarkers in tongue cancer invasion and mortality. Oral Oncol 2011, 47(4):282-287.
39. Preza D., Thiede B., Olsen I., Grinde B. The proteome of the human parotid gland secretion in elderly with and without root caries. Acta Odontol Scand 2009, 67(3):161-169.
40. Streckfus C.F., Mayorga-Wark O., Arreola D., Edwards C., Bigler L., Dubinsky W.P. Breast cancer related proteins are present in saliva and are modulated secondary to ductal carcinoma in situ of the breast. Cancer Invest 2008, 26(2):159-167.
41. Tiziana C., Barbara M., Federica I., Chiara F., Sonia N., Antonella F., et al. RP-HPLC-ESI-MS evidenced that salivary cystatin B is detectable in adult human whole saliva mostly as S-modified derivatives: S-glutathionyl, S-cysteinyl and S-S 2-mer. J Proteomics 2011, 75:908-913.
42. Nomura Y., Shimada Y., Hanada N., Numabe Y., Kamoi K., Sato T., et al. Salivary biomarkers for predicting the progression of chronic periodontitis. Arch Oral Biol 2012, 57:413-420.
43. Millea K.M., Krull I.S., Chakraborty A.B., Gebler J.C., Berger S.J. Comparative profiling of human saliva by intact protein LC/ESI-TOF mass spectrometry. BBA Proteins Proteomics 2007, 1774(7):897-906.
44. Kataoka H., Inoue R., Yagi K., Saito K. Determination of nicotine, cotinine, and related alkaloids in human urine and saliva by automated in-tube solid-phase microextraction coupled with liquid chromatography-mass spectrometry. J Pharm Biomed Anal 2009, 49(1):108-114.
45. Zenobi R., Knochenmuss R. Ion formation in MALDI mass spectrometry. Mass Spectrom Rev 1998, 17(5):337-366.
46. Vincent A., Herman J., Schulick R., Hruban R.H., Goggins M. Pancreatic cancer. Lancet 2011, 378(9791):607-620.
47. Hu S., Yu T., Xie Y., Yang Y., Li Y., Zhou X., et al. Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics 2007, 4(2):55-64.
48. Jou Y.J., Lin C.D., Lai C.H., Chen C.H., Kao J.Y., Chen S.Y., et al. Proteomic identification of salivary transferrin as a biomarker for early detection of oral cancer. Anal Chim Acta 2010, 681(1-2):41-48.
49. Jou Y.J., Lin C.D., Lai C.H., Tang C.H., Huang S.H., Tsai M.H., et al. Salivary zinc finger protein 510 peptide as a novel biomarker for detection of oral squamous cell carcinoma in early stages. Clin Chim Acta 2011, 412(15-16):1357-1365.
50. Terracciano R., Preiano` M., Palladino G.P., Carpagnano G.E., Barbaro M.P.F., Pelaia G., et al. Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases. Proteomics 2011, 11(16):3402-3414.
51. Hu S., Wang J., Meijer J., Ieong S., Xie Y., Yu T., et al. Salivary proteomic and genomic biomarkers for primary Sjo¨gren's syndrome. Arthritis Rheum 2007, 56(11):3588-3600.
52. Imanguli M.M., Atkinson J.C., Harvey K.E., Hoehn G.T., Ryu O.H., Wu T., et al. Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation. Exp Hematol 2007, 35(2):184-192.
53. Huang C.M., Zhu W. Profiling human saliva endogenous peptidome via a high throughput MALDI-TOF-TOF mass spectrometry. Comb Chem High Throughput Screen 2009, 12(5):521-531.
54. Popescu I.D., Albulescu R., Raducan E., Dinischiotu A., Tanase C. Applications of SELDI-TOF technology in cancer biomarkers discovery. Rom Biotechnol Lett 2010, 15:5654-5667.
55. Chibo L. The application of SELDI-TOF-MS in clinical diagnosis of cancers. J Biomed Biotechnol 2011, 2011:1-6.
56. Shintani S., Hamakawa H., Ueyama Y., Hatori M., Toyoshima T. Identification of a truncated cystatin SA-I as a saliva biomarker for oral squamous cell carcinoma using the SELDI ProteinChip platform. Int J Oral Maxillofac Surg 2010, 39(1):68-74.
57. Barzaghi D., Isbister J.D., Lauer K.P., Born T.L. Use of surface-enhanced laser desorption/ionization -time of flight to explore bacterial proteomes. Proteomics 2004, 4(2):2624-2628.
58. Ryu O.H. Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology 2006, 45(9):1077-1086.
59. Schipper R., Loof A., De Groot J., Harthoorn L., Dransfield E., Van Heerde W. SELDI-TOF-MS of saliva: methodology and pre-treatment effects. J Chromatogr B 2007, 847(1):45-53.
60. Papale M., Pedicillo M.C., Di Paolo S., Thatcher B.J., Lo Muzio L., Bufo P., et al. Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF/MS): from sample collection to data analysis. Clin Chem Lab Med 2008, 46(1):89-99.
61. Silberring J., Ciborowski P. Biomarker discovery and clinical proteomics. Trends Anal Chem 2010, 29(2):128-140.
62. Magni F., Van Der Burgt Y.E.M., Chinello C., Mainini V., Gianazza E., Squeo V., et al. Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry. Blood Transfus 2010, 8(Suppl. 3):s92-s97.
63. Rao P.V., Reddy A.P., Lu X., Dasari S., Krishnaprasad A., Biggs E., et al. Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res 2009, 8(1):239-245.
64. Streckfus C., Bigler L., Dellinger T., Kuhn M., Chouinard N., Dai X. The expression of the c-erbB-2 receptor protein in glandular salivary secretions. J Oral Pathol Med 2004, 33:595-600.
65. Kondo T. Tissue proteomics for cancer biomarker development: laser microdissection and 2D-DIGE. J Biochem Mol Biol 2008, 41(9):626-634.
66. Zhu W., Smith J.W., Huang C.M. Mass spectrometry-based label-free quantitative proteomics. J Biomed Biotechnol 2010, 2010:1-6.
67. Wu W.W., Wang G., Baek S.J., Shen R.F. Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel-or LC-MALDI TOF/TOF. J Proteome Res 2006, 5(3):651-658.
68. Krizkova S., Zitka O., Adam V., Kizek R., Masarik M., Stiborova M., et al. Assays for determination of matrix metalloproteinases and their activity. Trends Anal Chem 2011, 30(11):1819-1832.
69. Wong D., Zhang L., Farrell J., Zhou H., Elashoff D., Gao K., et al. Salivary biomarkers for pancreatic cancer detection. J Clin Oncol 2009, 27:4630.
70. De Jong E.P., Xie H., Onsongo G., Stone M.D., Chen X.B., Kooren J.A., et al. Quantitative proteomics reveals myosin and actin as promising saliva biomarkers for distinguishing pre-malignant and malignant oral lesions. Public Libr Sci 2010, 5(6):e11148.
71. Patel V.J., Thalassinos K., Slade S.E., Connolly J.B., Crombie A., Murrell J.C., et al. A comparison of labeling and label-free mass spectrometry-based proteomics approaches. J Proteome Res 2009, 8(7):3752-3759.
72. Chelius D., Bondarenko P.V. Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J Proteome Res 2002, 1(4):317-323.
73. Liu H., Sadygov R.G., Yates J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004, 76(14):4193-4201.
74. Rudney J.D., Staikov R.K., Johnson J.D. Potential biomarkers of human salivary function: a modified proteomic approach. Arch Oral Biol 2009, 54(1):91-100.
75. Streckfus C.F., Bigler L.R., Zwick M. The use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to detect putative breast cancer markers in saliva: a feasibility study. J Oral Pathol Med 2006, 35:292-300.
76. Nicholas B.L., Skipp P., Barton S., Singh D., Bagmane D., Mould R., et al. Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 181(10):1049-1060.
77. Yang L.L., Liu X.Q., Liu W., Cheng B., Li M.T. Comparative analysis of whole saliva proteomes for the screening of biomarkers for oral lichen planus. Inflamm Res 2006, 55(10):405-407.
78. Delaleu N., Immervoll H., Cornelius J., Jonsson R. Biomarker profiles in serum and saliva of experimental Sjo¨gren's syndrome: associations with specific autoimmune manifestations. Arthritis Res Ther 2008, 10(1):R22.
79. Giannobile W.V., Beikler T., Kinney J.S., Ramseier C.A., Morelli T., Wong D.T. Saliva as a diagnostic tool for periodontal disease: current state and future directions. Periodontology 2000 2009, 50(1):52-64.
80. Ghallab N., Shaker O. Salivary-soluble CD44 levels in smokers and non-smokers with chronic periodontitis: a pilot study. J Periodontol 2010, 81(5):710-717.
81. Brooks M.A.I.N., Wang J., Li Y., Zhang R., Elashoff D., Wong D.T. Salivary protein factors are elevated in breast cancer patients. Mol Med Rep 2008, 1(3):375-378.
82. Zhang L., Farrell J.J., Zhou H., Elashoff D., Akin D., Park N.H., et al. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology 2010, 138(3):949-957.